The importance of metabolic switching as a mechanism for FOXO3a up-regulation in slowing growth of breast cancer cells has been reported in one study only, probably because the published studies have limited their focus to analysis of death and death pathways. This evidence concerns the gene FOXO3 and breast carcinoma.